Literature DB >> 1460146

Introduction to special section: comorbidity and treatment implications.

P C Kendall1, J F Clarkin.   

Abstract

This article initiates the special section on comorbidity and treatment implications. The presence of comorbidity is recognized, the multiple meanings of comorbidity are mentioned, and an invitation for much-needed research on comorbidity and related treatment is extended.

Mesh：

Year:  1992        PMID： 1460146

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN： 0022-006X


  7 in total

Review 1.  Stability and course of personality disorders: the need to consider comorbidities and continuities between axis I psychiatric disorders and axis II personality disorders.

Authors:  C M Grilo; T H McGlashan; A E Skodol
Journal:  Psychiatr Q       Date:  2000

Review 2.  Co-occurring anxiety and disruptive behavior disorders: the roles of anxious symptoms, reactive aggression, and shared risk processes.

Authors:  Jennifer L Bubier; Deborah A G Drabick
Journal:  Clin Psychol Rev       Date:  2009-08-21

3.  Comorbidity: A sign of the times.

Authors:  R T Pivik
Journal:  J Psychiatry Neurosci       Date:  1997-03       Impact factor: 6.186

4.  Problems for the Book of Problems? Diagnosing Mental Health Disorders Among Youth.

Authors:  Philip C Kendall; Deborah A G Drabick
Journal:  Clin Psychol (New York)       Date:  2010-12

Review 5.  Recent research of relationships among eating disorders and personality disorders.

Authors:  Carlos M Grilo
Journal:  Curr Psychiatry Rep       Date:  2002-02       Impact factor: 5.285

Review 6.  The comorbidity of personality disorders in eating disorders: a meta-analysis.

Authors:  Monica Martinussen; Oddgeir Friborg; Phöbe Schmierer; Sabine Kaiser; Karl Tore Øvergård; Anna-Lena Neunhoeffer; Egil W Martinsen; Jan H Rosenvinge
Journal:  Eat Weight Disord       Date:  2016-12-19       Impact factor: 4.652

7.  Desipramine blocks alcohol-induced anxiety- and depressive-like behaviors in two rat strains.

Authors:  Bruk Getachew; Sheketha R Hauser; Robert E Taylor; Yousef Tizabi
Journal:  Pharmacol Biochem Behav       Date:  2008-06-29       Impact factor: 3.533
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.